USPTO serial 88749016
RX EVERYONE EVERYWHERE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- NOVAKOVIC, MIROSLAV
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RX EVERYONE EVERYWHERE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joshua G. Gigger
Joshua G. Gigger STOEL RIVES LLP201 SOUTH MAIN STREET, SUITE 1100SALT LAKE CITY, UT 84111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software in the nature of a mobile application for use in providing information relating to electronic health records and clinical trials | ACTIVE | — |
| 035 | Pharmaceutical and pharmacy services, namely, processing and dispensing online and telephone prescription orders for online clinical and retail pharmacies; maintaining a registry of national and international databases in the field of pharmaceuticals, medical devices, clinical trials, and healthcare; maintaining databases of pharmacies, pharmacists, and other healthcare professionals who can assist with the delivery of pharmaceutical services; retail pharmacy services; online retail pharmacy services; mail order pharmacy services; promoting the exchange of information and resources within the pharmaceutical, medical device, clinical trial, and medical communities to achieve advances in the fields of clinical research and healthcare; providing a website featuring statistical data and feedback on healthcare provider's performance for the purpose of assisting prospective patients in making physician, pharmacist, and other healthcare professional selection decisions; recruitment advertisement services, namely, posting of clinical trial notices for the purposes of providing clinical trial status, and recruiting and informing patients for participation in clinical trials for the testing of drugs and medical devices; providing needed information on the topics of healthcare operations management for promoting patient satisfaction via a global computer network; global patient relationship management services; and global consulting services in the field of patient relationship management for healthcare providers | ACTIVE | — |
| 036 | Pharmacy benefit management services | ACTIVE | — |
| 039 | Pharmacy packaging services, namely, packaging, labeling, aligning and sorting medication by date and time into individual packages and containers for patients and healthcare professionals; delivery of goods for others, namely, delivery of medication, device and clinical supply packages and containers by date and time and category for patients and healthcare providers | ACTIVE | — |
| 042 | Pharmaceutical and medical device services, namely, providing pharmacist medical and scientific research counseling services to patients and healthcare providers as well as patients and healthcare providers participating in clinical trials for pharmaceutical, biotechnology, and medical device development and testing; providing a website featuring online non-downloadable software applications used for providing information about healthcare, and investigational medical devices, diagnostics and pharmaceuticals; providing online, non-downloadable software for use in providing information relating to electronic health records; medical and scientific research information in the field of healthcare; conducting clinical trials for others | ACTIVE | — |
| 044 | Dispensing of medications by date and time and category for patients and healthcare providers; population health services, namely, gathering of global patient healthcare and behavioral data for the benefit of improving healthcare for individual patients, groups of patients, and populations; pharmaceutical advice; preparation of prescriptions in pharmacies; dispensing of pharmaceuticals; providing healthcare information; medical and pharmaceutical consultation; medical and pharmaceutical counseling via online or remote communication means; medical drug monitoring and alert service for healthcare providers and patients, namely, providing medication therapy management, medicinal dosage, allergic sensitivity, and prescription safety information for medical treatment purposes; telemedicine services; telepharmacy services, namely, providing medical and pharmaceutical consultation and advice via online or remote communication means; providing information to patients in the field of administering, use and storage of medications; and providing medical information to patients in the form of reports in the field of pharmaceuticals and medical devices | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by RXE2 LLC
- Other trademarks owned by RXE2 LLC
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RX EVERYONE EVERYWHERE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 1, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 1, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 29, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 4, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 4, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 14, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 31, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 1, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 31, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 30, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 30, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 30, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 29, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 22, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 22, 2020 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 22, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 22, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 22, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 1, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 31, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 31, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 31, 2020 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Mar 31, 2020 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Mar 31, 2020 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Mar 31, 2020 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Mar 26, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 10, 2020 | NWAP | NEW APPLICATION ENTERED | — |